COVID-19 Testing Markets, 2023

COVID-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023.

The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of a wide selection of diagnostic tests in all markets. Diagnostics have been critical in the response to COVID-19.

This report provides market sizing and estimates for COVID-19 tests with discussion of market impacts of COVID-19.

Some of the key topics and trends explored include:

  • At-Home Testing
  • Insurance Coverage
  • Multiplex Testing
  • Expiration of Public Health Emergency
  • New Variants on the Horizon
  • Immunoassay Testing
  • Molecular Testing
Table of Contents
  • Chapter 1: Executive Summary
    • Industry at a Glance
    • Scope and Methodology
    • Size and Growth of the Market
    • Key Issues and Trends Affecting the Market
    • Competitive Outlook
    • Conclusion Highlights
  • Chapter 2: Introduction
    • Overview
  • Chapter 3: Issues and Trends
    • At-Home Testing
    • Insurance Coverage
    • Multiplex Testing
    • EUAs and Public Health Emergency Expiration
    • New Variants On the Horizon
  • Chapter 4: COVID-19 Immunoassay Testing
    • Overview
      • Enzyme-linked Immunosorbent Assay (ELISA)
      • Mass Spectrometry
      • Rapid
    • Products
      • Antigen
      • Antibody
    • Market Size and Growth
    • Competitive Market Share
  • Chapter 5: COVID-19 Molecular Testing
    • Overview
    • Products
    • Market Size and Growth
    • Competitive Market Share
  • Chapter 6: Total COVID-19 Testing Market Summary
    • Market Overview
    • Market Segment by Test Type/Site
      • Laboratory Based
      • Point of Care
    • Market by Region
    • Competitive Analysis
  • Chapter 7: Selected Market Participants
    • Abbott
      • Company Overview
      • COVID-19
    • Access Bio, Inc
      • Company Overview
      • COVID-19
    • Becton-Dickinson
      • Company Overview
      • COVID-19
    • bioMérieux
      • Company Overview
      • COVID-19
    • Bio-Rad
      • Company Overview
      • COVID-19
    • Cue Health
      • Company Overview
      • COVID-19
    • Danaher Corporation
      • Company Overview
      • COVID-19
    • DiaSorin S.p.A.
      • Company Overview
      • COVID-19
    • ELITech Group S.A.S.
      • Company Overview
      • COVID-19
    • Genedrive plc
      • Company Overview
      • COVID-19
    • Hologic, Inc
      • Company Overview
      • COVID-19
    • LumiraDx UK Limited
      • Company Overview
      • COVID-19
    • OraSure Technologies, Inc.
      • Company Overview
      • COVID-19
    • PerkinElmer, Inc
      • Company Overview
      • COVID-19
    • QIAGEN N.V.
      • Company Overview
      • COVID-19
    • QuantuMDx Group, Ltd.
      • Company Overview
      • COVID-19
    • QuidelOrtho Corporation
      • Company Overview
      • COVID-19
    • Roche Diagnostic Corporation
      • Company Overview
      • COVID-19
    • Seegene, Inc
      • Company Overview
      • COVID-19
    • Siemens Healthineers GmbH
      • Company Overview
      • COVID-19
    • Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
      • Company Overview
      • COVID-19
    • ThermoFisher Scientific
      • Company Overview
      • COVID-19